Our Leadership

Dr. Michael Harrison

Chief Executive Officer

Dr. Harrison brings over 25 years of pharmaceutical industry experience, having previously served as VP of Operations at major pharmaceutical companies. He holds a PhD in Pharmaceutical Sciences from Harvard University and has been instrumental in bringing over 15 life-saving medications to market.

Dr. Sarah Chen

Chief Medical Officer

Dr. Chen is a renowned physician-scientist with expertise in clinical research and drug development. She has published over 100 peer-reviewed articles and has been recognized for her contributions to cardiovascular medicine. She earned her MD from Johns Hopkins and completed her residency at Mayo Clinic.

Dr. Robert Martinez

Chief Scientific Officer

Dr. Martinez leads our research and development initiatives with a focus on innovative drug discovery. With a PhD in Biochemistry from MIT, he has over 20 years of experience in pharmaceutical research and holds 12 patents in drug formulation and delivery systems.

Jennifer Thompson

Chief Financial Officer

Jennifer brings extensive financial expertise to Vaga Pharmaceuticals, having previously served as CFO at several Fortune 500 healthcare companies. She holds an MBA from Wharton School and is a CPA with specialization in pharmaceutical industry financial management.

Dr. Ahmed Patel

Director of Quality Assurance

Dr. Patel ensures the highest quality standards across all our manufacturing processes. With a PhD in Chemical Engineering and 18 years of experience in pharmaceutical quality control, he has implemented quality systems that exceed FDA and international regulatory requirements.

Lisa Rodriguez

Director of Regulatory Affairs

Lisa oversees all regulatory compliance and submissions for Vaga Pharmaceuticals. She has successfully managed over 50 FDA approvals and holds a Master's in Regulatory Science. Her expertise ensures our products meet all safety and efficacy standards globally.